Since in FAP patients, non-steroidal anti-inflammatory drugs cause adenomas to regress, it is tempting to suggest that this effect could be mediated through the lowering of PGE2 levels, which in turn reduce LGR5 expression and the survival of LGR5+ adenoma stem cells [72]. This evidence concerns the gene LGR5 and Familial adenomatous polyposis.